Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2025-12-27 @ 7:30 PM
Study NCT ID:
NCT01914003
Status:
COMPLETED
Last Update Posted:
2017-11-06
First Post:
2013-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)
Sponsor:
QOL Medical, LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
S2002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |